Hormonal treatments for endometriosis may lead to reduced bone mineral density in reproductive-aged women and people assigned female at birth.

Stroke risk is similar among individuals with migraine with aura who use combined oral contraceptives or progestogen-only pills.

The FDA approved Genglycos (pariglasgene brecaparvovec-opnr) to reduce daily cornstarch intake in patients aged 8 years and older with glycogen storage disease type Ia.

The FDA has authorized the Aletta as the first standalone robotic device that can draw blood from a patient's arm.